“anaplastic-large-cell-lymphoma” Archives

in
Entry Author Date Location
Seattle Genetics Gets $138M in First-Year Sales of Cancer Drug 02/12/13 Seattle
Seattle Genetics, Millennium Cancer Drug Cleared in EU 10/31/12 Seattle
Seattle Genetics Misses 1st Quarter Sales Estimate, But Sees $1B Future 05/08/12 Seattle
Seattle Genetics Sees Updated Side Effect Warning in Drug Label 01/13/12 Seattle
Seattle Genetics, Millennium Look to Broaden Reach of Hodgkin’s Drug 12/09/11 Seattle
Video: Seattle Genetics CEO Makes the Case for a $100K Cancer Drug 08/22/11 Seattle
Seattle Genetics Sets Lymphoma Drug Price at $13,500 Per Dose 08/22/11 Seattle
Seattle Genetics: The Next Litmus Test for High Priced Cancer Drugs 08/22/11 National
SeaGen Passes FDA Panel, Ken Stuart’s Journey to Seattle Biomed, the Latest M&A Obsession, & More Seattle-Area Life Sciences News 07/21/11 Seattle
Seattle Genetics’ New ‘Empowered Antibody’ Looks Clean in FDA Staff Documents 07/12/11 Seattle
Seattle Genetics’ FDA Panel Preview: What You Need to Know This Week 07/12/11 Seattle
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul 07/05/11 Seattle
Seattle Genetics Gets Some Love on National TV, as Cancer Drug Nears Market 01/14/11 Seattle
Seattle Genetics’ Home Run, NanoString’s Diagnostics Foray, PATH’s 50-Cent Vaccine, & More Seattle-Area Life Sciences News 12/09/10 Seattle
Seattle Genetics, Millennium’s Encore: Souped-Up Antibody Looks Better in 2nd Trial 12/07/10 Seattle
Seattle Genetics, Millennium Report Groundbreaking Results With Drug for Hodgkin’s 12/05/10 Seattle
Seattle Genetics, Millennium Nail 2nd Straight Trial With “Empowered Antibody” For Cancer 10/11/10 Seattle
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer 09/27/10 Seattle
Seattle Genetics Shows Re-Treatment Action 06/05/10 Seattle
Seattle Genetics Starts New Trial 06/18/09 Seattle
Page 1 of 1